Natural Killer (NK) Cells <table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Natural Killer (NK) Cells</th>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:0000623](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000623)</td>
</tr>
<tr>
<td class="label">Database</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology</td>
<td>[CL:0000623](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000623)</td>
</tr>
<tr>
<td class="label">Drug</td>
<td>Effect on NK Cells</td>
</tr>
<tr>
<td class="label">Interferon-α</td>
<td>Activation</td>
</tr>
<tr>
<td class="label">Glatiramer acetate</td>
<td>Modulation</td>
</tr>
<tr>
<td class="label">Fingolimod</td>
<td>Sequestration</td>
</tr>
<tr>
<td class="label">Dimethyl fumarate</td>
<td>Alteration</td>
</tr>
</table>
Introduction Natural Killer (Nk) Cells is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
...
Natural Killer (NK) Cells <table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Natural Killer (NK) Cells</th>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:0000623](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000623)</td>
</tr>
<tr>
<td class="label">Database</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology</td>
<td>[CL:0000623](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000623)</td>
</tr>
<tr>
<td class="label">Drug</td>
<td>Effect on NK Cells</td>
</tr>
<tr>
<td class="label">Interferon-α</td>
<td>Activation</td>
</tr>
<tr>
<td class="label">Glatiramer acetate</td>
<td>Modulation</td>
</tr>
<tr>
<td class="label">Fingolimod</td>
<td>Sequestration</td>
</tr>
<tr>
<td class="label">Dimethyl fumarate</td>
<td>Alteration</td>
</tr>
</table>
Introduction Natural Killer (Nk) Cells is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Natural Killer (NK) cells are innate lymphoid cells that provide rapid cytotoxic responses against stressed, infected, or malignant cells without prior sensitization. They bridge innate and adaptive immunity and have emerging roles in neuroimmune interactions relevant to neurodegeneration. [@earls2020]
Overview
Mermaid diagram (expand to render)
NK cells are large granular lymphocytes derived from common lymphoid progenitors in bone marrow. They constitute 5-15% of peripheral blood lymphocytes and are found in various tissues including spleen, liver, and uterine decidua. [@mandybur2021]
Surface Markers
CD56 (NCAM1) - major NK cell markerCD16 (FcγRIIIa) - antibody-dependent cellular cytotoxicityCD94 - NK cell receptor complexNKG2A/C/D/E - C-type lectin receptorsKIRs (KIR2DL, KIR3DL) - killer cell immunoglobulin-like receptorsNK Cell Subsets
CD56bright CD16dim - cytokine producers, regulatoryCD56dim CD16bright - cytotoxic effectorsCD56neg CD16pos - adaptive-like NK cells<!-- taxonomy-enrichment --> [@zhang2023]
<!-- multi-taxonomy-enrichment -->
Multi-Taxonomy Classification
Taxonomy Database Cross-References
PanglaoDB Marker Cross-References
External Database Links
[Cell Ontology (CL:0000623)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000623)
[OBO Foundry (CL:0000623)](http://purl.obolibrary.org/obo/CL_0000623)
[Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
[CellxGene Census](https://cellxgene.cziscience.com/)
[Human Cell Atlas](https://www.humancellatlas.org/)
[PanglaoDB](https://panglaodb.se/)
Taxonomy & Classification
PanglaoDB Marker Cross-References
External Database Links
[Cell Ontology (CL:0000623)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000623)
[OBO Foundry (CL:0000623)](http://purl.obolibrary.org/obo/CL_0000623)
[Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
[CellxGene Census](https://cellxgene.cziscience.com/)
[PanglaoDB](https://panglaodb.se/)
Functions
Cytotoxic Mechanisms
Granule-Dependent Killing
Perforin delivery to target cells
Granzymes (A, B, K) induce apoptosis
Fast acting (minutes)
NKG2D engagement (stress ligands)
Death receptor pathways (Fas/TRAIL)
Antibody-dependent cellular cytotoxicity (ADCC)
Cytokine Production
IFN-γ - antiviral, immunomodulatoryTNF-α - pro-inflammatoryIL-10 - anti-inflammatoryGM-CSF - myelopoiesisCCL3/MIP-1α - chemotaxisImmune Regulation
Interaction with dendritic cells
Modulation of adaptive immunity
Clearance of stressed cells
NK Cells in Neurodegeneration
Alzheimer's Disease
NK Cell Activity
Reduced NK cell cytotoxicity in AD patients
Altered NKG2D expression
Impaired IFN-γ production
Correlation with disease severity
Brain Infiltration
NK cells found in AD brain vasculature
Perivascular NK cell accumulation
Interaction with blood-brain barrier
Therapeutic Potential
NK cell modulation strategies
Enhancing immune surveillance
Targeting stress-induced ligands
Parkinson's Disease
NK Cell Findings
Decreased NK cell numbers in PD
Impaired cytotoxicity against α-synuclein targets
Altered KIR repertoire
Correlation with motor symptoms
α-Synuclein Interaction
NK cells can kill α-synuclein-expressing cells
NKG2D recognizes stressed dopamine neurons
Potential for immune clearance
Multiple Sclerosis
Dual Roles
Protective: antiviral activity, immune surveillance
Pathogenic: may attack CNS cells
MS therapies affect NK cell function
Clinical Correlations
NK cell counts predict relapse risk
Interferon-β increases NK cell activity
Natalizumab modulates NK cell trafficking
Stroke and Brain Injury
Post-Stroke Immunity
NK cells infiltrate damaged brain
Acute phase: pro-inflammatory
Subacute phase: regulatory functions
Neuroprotection
Clearance of dead cells
Prevention of autoimmunity
Promotion of repair
Neuroimmune Interactions
Blood-Brain Barrier
NK cells can cross BBB under inflammation
Regulation of BBB permeability
Interaction with endothelial cells
Neuronal Stress Signals
NKG2D ligands on stressed neurons
MICA/B expression in neurodegeneration
ULBP proteins in CNS pathology
Microglia Interaction
NK cells regulate microglia activation
Cross-talk via cytokines
Coordinated immune responses
Therapeutic Implications
NK Cell-Based Therapies
IL-15 therapy - NK cell expansionKIR mismatching - enhanced alloreactivityCAR-NK cells - targeted killingImmunomodulation
NKG2D antagonists
KIR blockade
Cytokine modulation
Drug Effects on NK Cells
See Also
T Cells
[B Cells](/cell-types/b-cells)
[Microglia](/cell-types/microglia)
[Neuroinflammation](/mechanisms/neuroinflammation-pathway)
[Innate Immune Response](/mechanisms/innate-immune-response)
[Alzheimer's Disease](/diseases/alzheimers-disease)
[Parkinson's Disease](/diseases/parkinsons-disease)
[Blood-Brain Barrier](/entities/blood-brain-barrier)
Background The study of Natural Killer (Nk) Cells has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
External Links
[PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
[Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
[Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data
Show full description